If you want to get off the fundraising start line, boost your total higher, or push yourself to raise even more for a cure then our dedicated community are here to help.

Celebrating You, The Brain Tumour Charity’s community awards event, returns in May 2020 and nominations are now open!

We’re delighted to announce our £1.35m investment in a pioneering drive to help accelerate research into brain tumours at one of the UK’s leading universities.

Our Research Communications & Engagement Officer, Arshiya, shares some of the most exciting results from the American Society of Clinical Oncology (ASCO) conference

Our Policy & Public Affairs Officer, Helena Brown, reports from Scotland

Our funded research has created a tool to help clinicians predict meningioma recurrence

Scottish scientist set to receive over £6 million from Cancer Research UK and The Brain Tumour Charity to find new ways to treat glioblastoma, one of the hardest types of cancer to treat.

In February, we co-signed a joint letter with other cancer charities to the Secretary of State for Health and Social Care which outlined concerns regarding cancer research in the UK post Brexit

Earlier this month, NHS England released their ‘Interim NHS People’s Plan’ detailing what measures will be implemented in and ahead of their full workforce proposal

Thanks to the support of our community, we’re pledging more than £3.7m to UK and international teams working towards our twin goals: doubling brain tumour survival and halving the harm caused by the disease

Most people find exams stressful and it’s safe to say that living with a brain tumour doesn’t make them any easier! Kaleb Ells, a member of our young adults community, has shared some of his top tips for getting through exam season.

After undergoing an interim analysis, a phase 3 clinical trial called Toca 5 that tests a gene therapy in patients with recurrent brain cancer, will continue

The Health Secretary, Matt Hancock, has spoken today of his frustration at slow progress towards embracing digital technology in the NHS.

Side by side, stride by stride, let’s pick up the pace of progress

Deputax-M failed to meet its target overall survival during an interim analysis of a phase 3 clinical trial in glioblastoma

Nivolumab, an immunotherapy drug, has been unsuccessful in improving overall survival in a phase 3 clinical trial when tested in newly diagnosed glioblastoma with unmethylated MGMT

Chartered Clinical Psychologist, Dr Nick Mooney, offers advice on how best to start talking with your family and friends about brain tumours.

New research from one of our funded grants gives much needed insight into group 3 and 4 medulloblastoma

There have been a number of headlines over the last two days about a ‘new treatment’ that may save thousands of lives for brain tumour patients

A new type of drug that targets a particular protein could become the first ever treatment designed for children with diffuse midline gliomas (formerly known as DIPG)

In preparation for Mental Health Awareness Week 2019, we’ve pulled together six top tips for looking after your mental health that are perfect for anybody affected by a brain tumour.

This weekend marks a year since Tessa Jowell died from a brain tumour

The Brain Tumour Charity held the first ever roundtable on brain tumours in Wales, bringing together a wide range of stakeholders within the brain tumour community to discuss what needs to be achieved to improve patient outcomes in Wales.

Research presented recently at a conference in Milan showed that a particular type of radiation therapy could help spare children’s memory and thinking when they undergo treatment for brain tumours